-transparent.png){kind=logo}
Only anti-coagulators and aggregation-stoppers may be said to be the medicamental prophylaxis of thromboembolism. The Cumarin-Indandion group is burdened with continuous laboratory controls. Contraindications excluding a general prophylaxis for this group as well as for Heparin and ASS exist. Infukoll, which is virtually always applicable, has the disadvantage that it has to be infused. Heparin- and Dextranspreparations however can already be used preoperatively, which means that a further decline of the coagulation complications can be expected.
Related Publications
F Flemming, and
E Thomas, and
R Widera
November 1977,
Langenbecks Archiv fur Chirurgie,
F Flemming, and
E Thomas, and
R Widera
November 1975,
Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
F Flemming, and
E Thomas, and
R Widera
January 1979,
Zentralblatt fur Chirurgie,
F Flemming, and
E Thomas, and
R Widera
February 1974,
MMW, Munchener medizinische Wochenschrift,
F Flemming, and
E Thomas, and
R Widera
September 1974,
MMW, Munchener medizinische Wochenschrift,
F Flemming, and
E Thomas, and
R Widera
January 1969,
Zentralblatt fur Gynakologie,
F Flemming, and
E Thomas, and
R Widera
June 1991,
Danish medical bulletin,
F Flemming, and
E Thomas, and
R Widera
July 1972,
Lancet (London, England),
F Flemming, and
E Thomas, and
R Widera
February 1977,
MMW, Munchener medizinische Wochenschrift,
F Flemming, and
E Thomas, and
R Widera
May 1980,
Wiener medizinische Wochenschrift (1946),
